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DOI: 10.1002/hsr2.117E D I TO R I A LTransparency and reproducibility: A step forwardAt Health Science Reports, we aim to publish scientifically sound and
reproducible research. A key aspect of this is proper reporting and open-
ness in all aspects of scientific communication. There is a growing
demand for transparency, openness, and reproducibility in research, and
several initiatives have been developed to try to address such needs.
In this editorial, we want to highlight some of the policies that the
journal has implemented or that will implement in the coming year to
support these efforts.1 | REPORTING
Reporting guidelines and standards are key to maximizing the quality
and transparency of the research process and publication. Accurate
and complete reporting enables readers to fully appraise research, to
replicate the research where necessary, and crucially, use and inter-
pret the research in an appropriate way.
Authors are currently encouraged to review the standards from the
EQUATOR network (http://www.equator‐network.org/) and follow
the relevant guidelines for the reporting of their specific study type
(eg, STROBE for observational studies). For manuscripts submitted
on or after March 1, 2019, and at manuscript submission, authors will
need to confirm that they have reviewed the standards in the net-
work, report whether any standards were relevant for their study,
and, when appropriate, confirm that they have followed those stan-
dards in the manuscript. The completed checklists may be requested
during the manuscript submission process and peer review.2 | AUTHORSHIP
Authorship implies responsibility and accountability for publishedwork.
We follow the International Committee of Medical Journal Editors
(ICMJE) criteria for authorship. Moreover, and with the goal of provid-
ing a clear and transparent description of the contributions made by
each author, we have implemented the Contributor Roles Taxonomy
(CRediT), a controlled vocabulary of contributor roles which aims to
improve accessibility and visibility of the range of contributions to pub-
lished research outputs1. Implementation of this initiative has been- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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https://doi.org/10.1002/hsr2.117seamless, and we will continue to request such statement, which we
believe has numerous important and practical benefits.
In addition, and considering ICMJE guidelines, from January 1,
2019, we have been requesting authors to state whether the source(s)
of support for the work or any other financial relationship, played any
role in study design; collection, analysis, and interpretation of the data;
writing of the report; or the decision to submit it for publication. Fur-
ther, we have been requesting that one named author (eg, lead author
or the manuscript guarantor) and no more than two authors indicate
that they had full access to all of the data and that they take complete
responsibility for its integrity and for the accuracy of its analysis. Sim-
ilarly, a statement certifying that all authors have read and approved
the final version of the manuscript, which is already being requested
as part of the submission process, will now be published with the
manuscript.
Lastly, articles submitted from March 1, 2019 onwards will need to
include a declaration of transparency,2 in which the lead author or the
manuscript guarantor will need to confirm that the manuscript is an
honest account of the study being reported.3 | DATA SHARING
Data sharing, such that key elements from a study are available to
peers for examination, replication, and validation, is an important
aspect of reproducibility and transparency, and it is being mandated
by an increasing number of funders.
As stated inWiley's data sharing policy, “the sharing of data enables
others to reuse experimental results and supports the creation of new
work built on previous findings, improving the efficiencies of the
research process, and supporting the critical goals of transparency and
reproducibility.” Indeed, we agree that such “open research,” if possible
in practice, facilitates faster and more effective research discovery.
For all manuscripts accepted on or after April 1, 2019,wewill require
a data sharing statement. Authors will need to state whether the data
and materials used to conduct the research will be made available to
any researcher for purposes of reproducing the results or replicating
the procedures. In practical terms, authors will need to indicate whetherwileyonlinelibrary.com/journal/hsr2 1 of 2
2 of 2 EDITORIALthe data and materials are available to the community, and, if so, how
andwhere to access them. Such data should followproper ethical guide-
lines and legal requirements for sharing, protecting participants' privacy.
For data that cannot be shared, a short description of the restriction will
need to be provided. If no data is associated with the article or all data
underlying the results presented are available in the article, this will also
need to be stated.
In addition, and following ICMJE guidelines, manuscripts submitted
to the journal that report the results of clinical trials must contain a
detailed data sharing statement, as described in Taichman et al.3 Fur-
ther, clinical trials that begin enrolling participants on or after January
1, 2019, must include a data sharing plan in the trial's registration.
While these statements will be required, they do not yet mandate data
sharing. We will monitor how these requirements evolve in
the community.
We hope that these initiatives, some of which are encompassed
under the “Transparency and Openness Promotion” (TOP) guidelines
(https://cos.io/top)—to which we adhere—will help us improve the
transparency and reproducibility of published articles, and we will con-
tinue to work with you, the community, to enhance the quality and
trustworthiness of medical research. We encourage authors to submit
replication studies to Health Science Reports, particularly those
attempting to reproduce findings reported in the journal, as such con-
tinued discussion is crucial for the advancement of science. Similarly,
we welcome study protocols, which increase transparency in the
design, conduct, and reporting of the resulting research articles.CONFLICTS OF INTEREST
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